Clinical Trials Logo

Clinical Trial Summary

This is a double-blind, sham-controlled clinical trial assessing the effectiveness of personalized isometric handgrip device therapy. Approximately 230 patients who present with a Systolic Blood Pressure reading of ≤ 149mmHg and who have not taken any antihypertensive medication for more than 30 days will be enrolled.


Clinical Trial Description

This study is designed to examine the effectiveness of individualized isometric handgrip device therapy in prehypertension or hypertension patient subjects who are not at target BP and who are naive to anti-hypertensive medication for at least 30 days before screening. The investigational plan examines changes in blood pressure (BP) in up to 230 patient subjects who are randomized to either the "active" (i.e., the Zona Plus device proposed for marketing), or to a "sham" device (which is intentionally calibrated for a "weaker grip"). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04467879
Study type Interventional
Source Zona Health, Inc
Contact
Status Terminated
Phase N/A
Start date June 1, 2020
Completion date September 14, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04874961 - Olive Polyphenols in Cardiovascular Prevention Phase 4
Recruiting NCT05903950 - Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure N/A
Recruiting NCT04423627 - Sympathetic Regulation of Large Artery Stiffness in Humans With ISH Early Phase 1
Recruiting NCT03457168 - Treatment of Hypertension During Sleep N/A
Recruiting NCT06059638 - BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT N/A
Completed NCT01650402 - Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People N/A
Recruiting NCT04463121 - Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06) N/A